Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657566 · ClinicalTrials.gov registry record · Phase 3
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
A Phase 3 study of Peritonitis, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 3
- Development phase
- 518
- Enrollment target
- 20
- Study locations
NCT00657566 is a Phase 3 study of Peritonitis that has completed, run by University of Virginia. The registered enrollment target is 518 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT00657566, a Phase 3 study of Peritonitis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 518 participants
- Enrollment target
- 20
- Study locations
Study Summary
The major hypothesis to be tested is that the treatment of intraabdominal infections that have been adequately treated operatively or by percutaneous techniques with three to five days of antibiotics will result in outcomes equivalent to the current standard where treatment is carried out until the patient has returned to normal (normal white blood cell count, temperature, and intestinal function), and that patients treated for three to five days will receive fewer days of antibiotics than the control group that has traditionally received seven to 14 days of treatment.
Conditions Studied
Interventions
- OTHER duration of antibiotics
Study Locations (20)
California
- University of California Davis - Sacramento
- University of California San Diego - San Diego
- University of California San Francisco - San Francisco
Kentucky
- Louisville-VA - Louisville
- Louisville-University Hospital - Louisville
Ohio
- Case Western - Cleveland
- Ohio State University - Columbus
Virginia
- University of Virginia - Charlottesville
- Medical College of Virginia-Virginia Commonwealth University Hospital - Richmond
Arizona
- Maricopa Medical Center-Phoenix - Phoenix
Florida
- University of Miami - Miami
Kansas
- Univestity of Kansas - Kansas City
Maryland
- Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00657566
The ClinicalTrials.gov registry entry for NCT00657566 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 518 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peritonitis appearing as the primary indexed condition, and to 1 intervention - of which duration of antibiotics is the first listed.
NCT00657566 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Kentucky, Ohio.
Frequently Asked Questions
What is clinical trial NCT00657566 about?
NCT00657566 is a clinical study titled "SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection". The major hypothesis to be tested is that the treatment of intraabdominal infections that have been adequately treated operatively or by percutaneous techniques with three to five days of antibiotics will result in outcomes equivalent to the current standard where treatment is carried out until the ...
What is the current status of trial NCT00657566?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 518 participants. The study started on 2008-09. Estimated completion is 2014-08.
What conditions does trial NCT00657566 study?
This clinical trial studies the following conditions: Peritonitis.
What interventions are being tested in trial NCT00657566?
The interventions under investigation include: duration of antibiotics (OTHER).
Who is sponsoring clinical trial NCT00657566?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00657566 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.